Lauren Jufiar
Psychiatric/Mental Health · Costa Mesa, CANPI 1588461867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations.
Across 188 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$552
- Vanda Pharmaceuticals Inc.$480
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$462
- Johnson & Johnson$320
- AbbVie$293
- Alkermes, Inc.$282
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 22 | $552 |
| Vanda Pharmaceuticals Inc. | 19 | $480 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $462 |
| Johnson & Johnson | 14 | $320 |
| AbbVie | 15 | $293 |
| Alkermes, Inc. | 10 | $282 |
| Teva Pharmaceuticals USA, Inc. | 18 | $255 |
| Otsuka America Pharmaceutical, Inc. | 10 | $234 |
| Noven Therapeutics, LLC | 9 | $170 |
| E.r. Squibb & Sons, L.L.C. | 7 | $158 |
| Braeburn Inc. | 6 | $124 |
| Supernus Pharmaceuticals, Inc. | 5 | $114 |
| Biogen | 4 | $110 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $93 |
| Lundbeck LLC | 4 | $62 |
| Corium, LLC | 2 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Idorsia Pharmaceuticals US Inc | 2 | $46 |
| Indivior Inc. | 2 | $35 |
| Luye Pharma (USA) Ltd. | 2 | $34 |
| Bausch Health US, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $16 |
How this compares
$4,092 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Costa Mesa
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
- Jonathan LlamasPasadena$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.